MAP2K1 and neoplasm: A total of 31 distinct MAP2K1 mutations were identified (Supplementary Table S2), with 20 tumours (19.6%) harbouring Class I mutations, 56 tumours (54.9%) having Class II mutations, and 26 tumours (25.5%) having Class III mutations (Table 1).